Skip to content
Search

Latest Stories

NHS introduces flash glucose monitors for all type 1 diabetes patients

Type 1 diabetes patients can monitor their glucose with the newly introduced flash glucose monitors by the NHS.

The wearable gadgets with the size of a £2 coin, have a sensor that easily sits on the arm, allowing patients to check their glucose levels with a one-second scan.


Eligible patients are currently able to access the monitors on prescription from their local GP or diabetes team, helping them to better manage their blood sugar levels.

Everyone living with type 1 diabetes will be eligible for lifechanging flash glucose monitors on the NHS. The NHS Long Term Plan has already helped almost three in five people with Type 1 diabetes to access the monitors that allow people to check their glucose levels more easily and regularly.

The change, confirmed today by the National Institute for Health and Care Excellence (NICE), means that everyone in England with the condition will be able to benefit from the convenient technology.

Monitors link to an easy to use app on your phone, where people can access the data gathered by the device. Unlike conventional monitors they allow patients to view patterns over time, not only showing current and previous glucose levels but also predicting what level they can rise to.

New research presented this week at the Diabetes UK Professional Conference 2022 revealed that flash monitoring not only helps to improve blood glucose levels in people with type 1 diabetes, but also has a positive effect on their quality of life.

The NHS Long Term Plan included a target to ensure 20 per cent of people with type 1 diabetes were benefiting from flash monitors by March 2021 and recent data shows the NHS significantly exceeded that goal, with nearly three fifths already accessing the technology.

The NHS is taking radical action to tackle and treat diabetes, including through the world leading NHS Diabetes Prevention Programme with new research showing thousands of people are being spared type 2 diabetes thanks to the scheme.

The NHS in England currently spends around £10 billion a year on diabetes – around 10 per cent of its entire budget. Tools like continuous glucose monitoring, which help patients better manage their condition and reduce associated illness and hospitalisations, can prove hugely cost effective.

National NHS Specialty Adviser for Diabetes, Professor Partha Kar, said: “This announcement is the biggest step forward for type 1 diabetes care in years, allowing everyone eligible to have one of these easy to use pieces of tech if they want to – building on the success of the NHS in its rollout so far. I am delighted to see NICE endorse the use of this technology.

“These monitors are a win win – they support diabetes patients to live healthier lives, reduce their risk of hospitalisation while also helping to reduce pressure on NHS services and provide better value for money for taxpayers”.

Olivia aged 25 from Essex, who was diagnosed with type 1 diabetes aged seven said: “Before I started using a flash glucose monitor, I carried my blood glucose testing kit with me everywhere and would have to test up to eight times per day – I was pricking my finger and testing my blood sugar before breakfast, before lunch, before dinner and before bed. Before driving in the car I would need to test, and after driving for two hours I would need to stop to test – endless testing!

“Growing up with diabetes, I’d never dreamed that a device like a flash glucose monitor, where you don’t need to finger prick to know what your levels are, would be developed in my lifetime – and when I first started using one, I couldn’t quite believe something so small had such an impact on managing my diabetes.

“Since using a flash monitor, I’ve seen a huge improvement as I can make informed decisions when taking my insulin by looking at trends. But, most importantly, it’s helped me have more confidence and improved my mental well-being”.

More For You

 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less